Saturday 17 October 2026 Export HALO’s income statement to Excel — free account

Halozyme Therapeutics, Inc.

Halozyme Therapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.4 billion, up 37.6% from fiscal 2024. In the quarter to June 2026, revenue grew 47.7%, EPS grew 44.1%, free cash flow grew 141.2% and total debt rose 42.2%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three.

121.84 0.33 +0.27%

Follow HALO

Alert me

Market cap: $13.8B
P/E: 34.6×
Fwd P/E: 10.6×
Dividend yield: —
F-score: 5/9
Altman Z: 3.46
Beneish M: −2.59
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
ROE Full definition →	+8 more TTM periods Free account	124.50%	153.59%	99.40%	173.67%
Piotroski F-Score Full definition →		8	5	5	5
ROA Full definition →		27.45%	13.81%	14.33%	17.86%
ROIC Full definition →		35.11%	14.31%	15.64%	18.13%
Return on Tangible Assets Full definition →		105.78%	43.39%	48.31%	61.47%
Average Days of Receivables Full definition →		101.62	115.33	110.82	100.00
Free Cash Flow per Share Full definition →		6.31	5.38	5.65	6.87
Free Cash Flow Full definition →		739.68	644.59	667.65	806.22
Capital Expenditures Full definition →		128.68	(6.97)	(9.76)	(12.37)
Other line items
Cash ROIC Full definition →		27.23%	27.61%	24.89%	31.98%
Accounts Receivable Turnover Full definition →		3.93	3.73	3.96	4.31
Accounts Payable Turnover Full definition →		13.84	14.69	15.19	13.83
Inventory Turnover Full definition →		1.21	1.44	1.62	1.84
Average Days of Payables Full definition →		29.19	33.34	19.82	29.47
Days of Inventory on Hand Full definition →		353.10	281.56	218.58	171.17
Tax Rate Full definition →		(0.20)	(0.32)	(0.31)	(0.29)
Research and Development Expense of Revenue Full definition →		5.63%	26.23%	25.00%	23.28%
Selling, General and Administrative Expense of Revenue Full definition →		13.86%	14.83%	14.76%	14.30%
Share Based Compensation of Revenue Full definition →		3.74%	3.69%	3.81%	3.79%
Interest Coverage Full definition →		41.53	25.87	26.79	29.41
Operating CF/Net income Full definition →		1.03	2.06	1.94	1.98
Depreciation/Fixed assets Full definition →		1.17	1.12	1.31	1.45
Capex/Depreciation Full definition →		1.54	(0.08)	(0.09)	(0.10)
Revenue per Share Full definition →		10.60	11.65	12.77	14.19
Operating CF per Share Full definition →		5.21	5.44	5.73	6.98
Capex per Share Full definition →		1.10	(0.06)	(0.08)	(0.11)
Capex to Sales Full definition →		(0.10)	0.01	0.01	0.01

Show all line items

Columns are period end dates

Stockrow Weekly